EY data released this week shows UK IPO proceeds more than trebled in H1 2026 versus H1 2025. With easyJet, ITV and a record M&A pipeline also making headlines, here’s whether London’s recovery is real — and what it means for investors.
A quiet few years for London’s stock market may be turning. EY data released on Wednesday shows that UK IPO proceeds more than trebled in H1 2026 compared with the first half of 2025, while the M&A market has also surged — with easyJet, ITV and Novartis’ acquisition of UK biotech Myricx all announced in a single week (Sharecast / EY, 7 July 2026).
But the picture is more complicated than the headline. The UK still lost two large companies to overseas listings in H1, and the IPO total was inflated by a stronger H2 2025 that pulled deals forward. Here’s an honest read of what’s actually happening on the London Stock Exchange.
EY’s H1 2026 UK IPO report, released on 7 July 2026, found that the amount raised through UK market debuts in the first six months of 2026 more than trebled compared with H1 2025. The firm cited improving market sentiment, regulatory reforms and a stamp duty exemption for newly listed companies as the key drivers of the recovery (Sharecast / EY, 7 July 2026).
However, context matters. Q1 2026 was notably weak: just two UK IPOs completed, as the AI sector sell-off and the Middle East conflict created volatility that caused companies to delay listings. The H1 2026 total was heavily weighted toward Q2, when conditions improved. EY’s own Q1 analysis noted that “much of the anticipated 2026 pipeline had been expected to concentrate on the second half of the year” (EY-Parthenon, April 2026).
Three structural changes to the UK’s listing framework have made London a more attractive destination for companies considering going public:
Together these reforms address some of the specific complaints that had caused companies to favour New York or Amsterdam over London for their listings.
23 companies listed on the London Stock Exchange in 2025, raising £2.1 billion — a 170% year-on-year increase in proceeds despite broadly unchanged deal volumes. EY described the London IPO market as entering 2026 on “the most constructive footing we’ve seen in several years”. (EY-Parthenon, January 2026)
While IPO volume measures new companies joining the stock market, the M&A market this week tells a related but different story: London-listed companies are attracting overseas buyers at a record pace, partly because of the same valuation discount that has been making UK listings appear cheap.
In a single week in early July 2026:
Reuters noted that “the British market is on course to set a mergers and acquisitions record in 2026 as weaker valuations among London-listed companies attract buyers” (Reuters, 5 July 2026). This is the paradox at the heart of the London story: the same valuation discount that attracts takeover bids is also what has been prompting some companies to consider listing in New York instead.
For more on accessing IPO opportunities, see IG’s guide to upcoming IPOs to watch.
The optimistic narrative has genuine data behind it — but so do the counterarguments:
EY describes the H2 2026 UK IPO pipeline as “strong”, with several sectors where activity is most likely:
For a view on what sectors and themes are attracting investment in 2026, see IG’s guide to top investment themes to watch in 2026.
Invest in UK equities with IG
Access FTSE 100 shares, IPOs and more.
Is the UK IPO market recovering in 2026?
EY data released on 7 July 2026 shows UK IPO proceeds more than trebled in H1 2026 compared to H1 2025. The recovery is driven by listing regime reforms — including simplified listing rules and a three-year stamp duty exemption for newly listed companies — alongside improved market sentiment in Q2. However, the recovery is partial: Q1 was very weak, delistings continue to outpace new listings, and the UK valuation discount versus US markets has not materially narrowed (EY-Parthenon, July 2026).
What changes has the UK made to attract more IPOs to London?
The Financial Conduct Authority overhauled the UK Listing Rules in 2024, replacing Premium and Standard segments with a single Commercial Companies category. Key changes include: removal of dual-class share restrictions for premium listings, reduction of minimum free float from 25% to 10%, and simplification of prospectus requirements. The 2025 Autumn Budget also introduced a three-year stamp duty exemption for shares in newly listed companies (EY-Parthenon, January 2026).
Why is the UK M&A market at record levels in 2026?
The UK M&A record pace in 2026 reflects a combination of the UK’s persistent valuation discount versus global peers (which makes London-listed companies cheaper for overseas buyers), an improving deal financing environment as interest rates gradually ease, and strong activity in sectors such as defence, technology and media. Reuters noted that “the British market is on course to set a mergers and acquisitions record in 2026 as weaker valuations among London-listed companies attract buyers” (Reuters, 5 July 2026).
How can UK investors participate in IPOs?
UK investors can access IPOs through IG’s share dealing accounts and ISAs. IG provides access to both UK and US IPOs, including pre-IPO price discovery through grey market pricing. See IG’s guide to upcoming IPOs to watch for the current pipeline. Capital at risk. The value of investments can go down as well as up.
What UK IPOs are expected in H2 2026?
EY describes the H2 2026 UK pipeline as “strong”, with defence and aerospace, AI infrastructure and financial services identified as the most active sectors. Several well-funded private companies in UK fintech and AI are at a stage where public markets are a natural next step. Specific IPO candidates are not publicly confirmed until a formal intention to float is announced (EY-Parthenon, April–July 2026).
This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary at ig.com/uk/non-independent-research-disclaimer.
Past performance is not a reliable indicator of future results.